A Study to Investigate the Genetic Variation of Dopamine Pathway in Patients With Chronic Pain

Plain-language summary

This study investigates the genetic variation of the dopamine pathway in patients with chronic pain. Participants provided a blood sample for genotyping and completed personality questionnaires. It included men and women aged 18 and over who had completed the earlier T1001-01 or T1001-02 studies. This was a study with no assigned phase and it has been completed.

The summary above is a plain-language rendering of the official record. The original English title is shown for reference.

Trial details

Phase

Not Applicable

Status

Completed

Sponsor

Tools4Patient

Intervention

Blood sampling for genotyping, Personality Questionnaires completion

Start date

2/8/2017

Estimated completion

10/5/2017

Countries

Belgium, France

Related genes

Locations

• Liège, Belgium
• Clermont-Ferrand, France
• Gières, France
• Paris, France

Eligibility criteria

Criteria are reproduced from the ClinicalTrials.gov record in the original English. Only the trial team can determine eligibility.

Inclusion Criteria:

* have completed T1001-01 or T1001-02 study (Visit 5 completed)
* are men or women of at least 18 years of age
* have given written informed consent approved by the relevant Ethics Committee governing the study sites

Exclusion Criteria:

* have any close relationship with the Investigators or the Sponsor
* are under legal protection, according to the national law